Skip to content
Screener

Embecta Corp. EMBC Q4 2025 Annual earnings

Reported November 25, 2025 · Before market open

Revenue$264.0MBeat by $5.8M
EPS$0.50Miss by $0.20
Revenue estimate$258.2M
EPS estimate$0.70

Next report

Nov 24, 2026 (in 2 months)
Revenue estimate$269.7M
EPS estimate$0.31

Financials

Q4 2025

Income statement

See full
Revenue$264.0M-7.7%
Gross profit$158.5M-8.8%
Operating income$56.5M+116%
Net income$26.4M+80.8%
EPS (diluted)$0.44+83.3%

Balance sheet

See full
Cash & equivalents$228.6M-16.6%
Total debt$1.4B-11.0%
Total equity-$650.6M+11.9%
Total assets$1.1B-15.1%

Cash flow

See full
Operating cash flow$84.0M+216%
CapEx$7.3M—
Free cash flow$76.7M+188%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$825.23M+1.3%
Enterprise value$2.04B-5.7%
P/E8.7×-1.8×
P/S0.8×0.0×

Profitability

See full
Gross margin62.6%-2.8pp
Operating margin22.4%+7.6pp
Net margin8.8%+1.9pp
FCF margin16.9%+15.1pp

Returns & leverage

See full
Current ratio2.4×+0.4×

Segments

By product

See full
Pen Needles$187.8M-12.7%
Safety$34.6M+5.2%
Syringes$32.3M-4.2%
Contract Manufacturing$5.2M+10.6%

FAQ

When did Embecta Corp. report Q4 2025 earnings?
Embecta Corp. (EMBC) reported Q4 2025 earnings on November 25, 2025 before market open.
What were Embecta Corp.'s Q4 2025 revenue and EPS?
Embecta Corp. reported revenue of $264.0M and eps of $0.50 for Q4 2025.
Did Embecta Corp. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $258.2M by $5.8M. EPS missed the consensus estimate of $0.70 by $0.20.
How did Embecta Corp.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 7.7% from $286.1M a year earlier and eps grew 11.1% from $0.45.
Where can I find Embecta Corp.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001872789-25-000033) and the 10-K periodic report (0001872789-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.